DIAGRAMA DE CASOS DE USO

Based on the findings of this study, I recommend that this hospital: i) Reviews the current VAP infection prevention strategies.

ii) Identifies sources of potential pathogens of VAP within the ICU milieu

iii) Develops an antibiotic use policy to guide prescribers and regulate use of antibiotics.

iv) Carry out further studies to establish susceptibility patterns of the individual antimicrobial agents commonly used in this ICU.

REFERENCES

Abbot V.A., Dremsa T., Stewart D .W., Mark D.D. and Sift C.C. (2006). Adoption of Ventilator associated pneumonia guidelines. World views on evidence based nursing 4(3): 139-152

Abilo T.and Alem.M (2006).Medical Bacteriology. University of Gondar.Addis Ababa.Ethiopia

Akkoyunlu Y., Öztoprak N., Aydemir, H. Pişkin N., Çelebi G., Ankarali L. and Akduman D. (2013). Risk factors for nosocomial pneumonia in ICU.Journal of microbiology and infectious diseases 3(1):3-7

Alcón A, Fàbregas N, Torres A. (2003). Hospital-acquired pneumonia: etiologic considerations. Infectious Diseases Clinical North American 7(4):679-95.

American Association of Respiratory Care (2004). AARC clinical practice guideline. Nasotracheal suctioning—2004 revision and update. Respiratory care journal 49 (9): 1080-1084

American Thoracic Society, Infectious Diseases Society of America (2005). Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American Journal Respiratory Critical Care Medicine 171:388–416.

Azoulay E., Timsit J.F., Tafflet M., de Lassence A., Darmon M., Zahar J.R., Adrie C., Garrouste-Orgeas M., Cohen Y., Mourvillier B. and Schlemme B. (2006). Candida colonization of the respiratory and subsequent Pseudomonas

ventilator-associated pneumonia. Chest 129:110–117

Bayram v. and Balci I. (2006). Patterns of antimicrobial resistance in a surgical intensive care unit of a university hospital in Turkey. BMC Infectious Diseases 6:155

Bonten M.J.M., Kollef M.H. and Hall J.B. (2004). Risk factor for ventilator- associated pneumonia. From epidemiology to patient management. Clinical Infectious Diseases 38 (8): 1141-1149

Brusselaers N., Vogelaers D and Blot S. (2011). The rising problem of antimicrobial resistance in the intensive care unit: Annals of Intensive Care 1:47.Tuberculosis

Respiratory Diseases (Seoul) 73(1): 32–37.

Esper A. M. and Martin G. S. (2011). The impact of comorbid conditions on critical illness. Critical Care Medicine 39(12):2728-35

Cillóniz C., Polverino E., Ewig S., Aliberti S., Gabarrús A., Menéndez R., Mensa J., Blasi F.and Torres A. (2013). Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. Chest 144(3):999-1007.

Clinical Laboratory Standards Institute (CLSI) (2010). Performance Standards for antimicrobial susceptibility testing. Twentieth informational supplement interpretive criteria. European Journal of Clinical Microbiology and Infectious Diseases 29(3): 377-400

Chester J. and Fagon J.Y. (2002).Ventilator associated pneumonia. American Journal of Respiratory and Critical Care Medicine 165 (7): 867-903

CDC (2013). July 2013 CDC/NHSN Protocol Clarifications

Cook D. (2007).Ventilator associated pneumonia. Perspectives of the burden of illness. Intensive Care Medicine 26 (13): 1421–1427

Craven D.E. and Hjalmarson K.I. (2010). Ventilator-Associated Tracheobronchitis and Pneumonia: Thinking Outside the Box: Clinical Infectious Diseases 51 (S1): S59- S66.

Craven D.E.and Steger K.A. (1995). Epidemiology of nosocomial pneumonia. New perspectives on an old disease. Chest 108 (Suppl.): 1-16

Dodek P., Keenan S., Mehta H.J., Cook D. and Heyland D. (2004). Evidence based clinical practice guidelines for prevention of ventilator associated pneumonia.

Annals of Internal Medicine 141:305-313

Dominguez A.A., Arango M.V. and Torres A. (2006). Treatment failure in patients with ventilator-associated pneumonia. Respiratory Critical Care Medicine 27(1):104-

114

El-Saed A., Balkhy H.H., Al-Dorzi H.M., Khan R., Rishu A.H. and Arabi Y.M. (2013), Acinetobacter is the most common pathogen associated with late-onset and recurrent ventilator-associated pneumonia in an adult intensive care unit in Saudi Arabia. International Journal Infectious Disease 17(9):696-701.

Esper A. M. and Martin G. S. (2011). The impact of comorbid conditions on critical illness. Critical Care Medicine 39(12):2728-35

Fagon J.Y. (2006). Targeted antibiotic therapy for ventilator associated pneumonia. Clinical microbiology and infection 12 (supp 9): 17-22

Foglia E. M. and Elward A. (2007). Ventilator-associated pneumonia in neonatal and pediatric intensive care unit patients. Clinical Microbiology Review 20:409–425

Fowler R.A., Sabur N., Li P., Juurlin D.N., Pinto R., Hladunewich M.A., Adhikari N.K., Sibbald W.J. and Martin C.M. (2007). Sex-and age-based differences in the delivery and outcomes of critical care. Canadian Medical Association Journal 177(12):1513-9.

Fuchs L., Chronaki C., Park S., Novack V., Baumfeld., Scott D., McLennan S., Talmor D.and Celi. (2012). ICU admission characteristics and mortality rates among elderly and very elderly patients. Intensive Care Medicine 38(10): 1654-1661

Gastmeier, p., Sohr D., Geffers C.,Rüde H.,Vonberg R. and Welte T. (2009). Early- and Late-Onset Pneumonia. Is this still a useful classification? AntimicrobIal Agents Chemotheraphy 53(7): 2714-2718

Goel V., Hogade S.A. and Karadesai S.G. (2012).Ventilator associated pneumonia in a medical intensive care unit. Microbial aetiology, susceptibility patterns of isolated microorganisms and outcome. Indian Journal of Anesthesia 56(6): 558–562.

Grap M.L., Monroe S., Sessler R, K., Ward K.and Elswick R.K. (2004). Duration of action of single, early oral application chlorhexidin on oral microbial flora in mechanically ventilated patients. A pilot study. The journal of acute and critical care

33: 83-91

Grgurich P, E., Hudcova J., Lei Y., Sarwar A. and Craven D.E. (2013). Diagnosis of ventilator-associated pneumonia. Controversies and working toward a gold standard. Current Opinion. Infectious Diseases 26(2)

Gupta A., Agrawal A.,Mehrotra S., Malik A.M. and Khanna A. (2011).Incidence, risk stratification, antibiogram of pathogens isolated and clinical outcome of ventilator associated pneumonia. Indian Journal Critical Care Medicine 15(2):96-101 Hidron A.I., Edwards J.R. and Patel J. (2008). NHSN annual update. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006 – 2007. Infection Control Hospital Epidemiology 29:996–1011

Hixson S.J., Sole M.L., Lloyd R.C. and King T. (1998). Nursing strategies to prevent ventilator acquired pneumonia. AACN clinical issues. Advanced practice in acute care 9:76-90

Hutchins K., Karras G., Erwin J., Kevin L. and Sullivan K.L. (2009). Ventilator- associated pneumonia and oral care. A successful quality improvement project.

American journal of infection 37(7):590-597

Jaggi N., Sissodia P. and Sharma L. (2012). Acinetobacter baumannii isolates in a tertiary care hospital: Antimicrobial resistance and clinical significance. Journal of microbiology and infectious diseases 2 (2): 57-63

Jaimes F.E., De La Rosa G., Gomez E., Munera P., Ramirez. and Castrillon S. (2007). Incidence and risk factors for ventilator-associated Pneumonia in a developing country. Where is the difference? Respiratory Medicine 101:762–767

Jaimes F.E., De La Rosa G., Gomez E., Munera P.,Ramırez J. and Castrillon.S. (2011). Bacteremia is an independent risk factor for mortality in nosocomial pneumonia. A prospective and observational multicenter study. Critical Care 15:R62

Johani S.M.,Akhter J., Balkhy H., El-Saed A., Younan M. and Memish Z .(2010). Hospital acquired antibiotic-resistant Acinetobacter baumannii infections in a 400-bed hospital in Tehran, Iran. Annals Saudi Medicine 30(5): 364–36

Jones R.N. (2010). Etiologies of HABP and VABP. Clinical Infectious Diseases 51(S1):S81–S87

Jones R N., Farrell D. J., Mendes R E.and Sader H.S. (2011). Comparative ceftaroline activity tested against pathogens associated with community-

acquired pneumonia: results from an international surveillance study. Journal of

Antimicrobial Chemotheraphy. 66 (S 3): 69-80.

Joseph N.V., Sistla S., Dutta T.K., Badhe A.S., Rasitha. D. and Parij S.C. (2010). Ventilator-associated pneumonia in a tertiary care hospital in India. Role of multi- drug resistant pathogens. Journal Infections Developing Countries 4(4): 218-225 Joseph N, M., Sistla D., Dutta T., Badhe A.S., Rasitha D.P. and Subhash. C. (2012). Role of intensive care unit environment and health-care workers in transmission of ventilator-associated pneumonia. Journal of Infection in Developing Countries 4 (5):282-291

Klompas M. (2012). Is a ventilator-associated pneumonia rate of zero really possible? Current Opinion in Infectious Diseases 25 (2): 176–182

Klompas M., Kulldorff M. and Platt R. (2008). Risk of misleading ventilator- associated pneumonia rates with use of standard clinical and microbiological criteria. Clinical Infectious Diseases 46 (9): 1443-1446

Koenig S.M. and Truwit J.D. (2006). Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention. Clinical Microbiology Review 19(4): 637–657.

Kollef M.H. (2004). Prevention of hospital acquired pneumonia and ventilator associated pneumonia. Critical care medicine 34: 1396-1405

Lin S.H., Lai C.C., Tan C.K.,Liao W.H. and Hsueh P.R.(2011). Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumonia: Epidemiology Infection 139(9): 1307-16.

Madani N., Rothenthal V.D., Dendane T., Abidi K.J., Zeggwagh A.A. and Abouq R. (2009). Health care associated infections rates, length of stay and bacterial resistance in an intensive care unit of Morocco. Findings of the international nosocomial infection control consortium (INCC). International Archives of medicine 2(29):2-29

Magret M. T., Lisboa I., Martin-Loeches R., Máñez M. , Nauwynck H., Wrigge S., Cardellino E., Díaz D., Koulent D. and Rello.J.(2011). EU-VAP/CAP Study Group. Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study. Critical Care 15: R62.

Meersseman W., Lag K. Spriet I., Maertens J., Verbeken E. Peetermans W. and Van Wijngaerden E. (2009). Significance of the isolation of Candida species from airway samples in critically ill patients. A prospective, autopsy study. Intensive Care Medicine 35:1526–1531

Michetti C.P., Fakhry S.M., Ferguson P.L., Cook A., Moore F.O. and Gross A. (2012). Ventilator-associated pneumonia rates at major trauma centers compared with a national benchmark: a multi-institutional study of the AAST. Journal Trauma Acute Care Surgery 72(5):1165-73.

Munro C.L., Grap M.J., Elswick R.K., McKinney J, Sessler C.N. (2006 Oral Health Status and Development of Ventilator-Associated Pneumonia: A Descriptive Study.

American Journal Critical Care 15(5): 453-460

Munoz-Price L.S., Robert A. and Weinstein R.A. (2008). Acinetobacter Infection. Current concepts. New English journal Medicine 358:1271-1281

Napolitano M. (2010). Use of severity scoring and stratification factors in clinical trials of hospital-acquired and ventilator-associated pneumonia. Clinical Infectious Diseases 51 (S1): S67-S80

Nguyen Y., Angus D.C., Boumendil A. and Guidet B. (2011).The challenge of admitting the very elderly to intensive care. Annals of Intensive Care 1:29

Orodho J. A. (2010). Techniques of writing research proposals and reports in educational and social sciences. Nairobi. Kanezia HP Enterprises

Parker C.M., Kutsogiannis J., Muscedere J., Cook D., Dode P., Day A.G. and Heyland D.K.(2010).Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa. Prevalence, incidence, risk factors, and outcomes. Journal of critical care 23(1):18-26.

Parker C.M., Kutsogiannis, J., Muscedere J., Cook D., Dodek. P., Day A.G, and Heyland, D.K. (2006). Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa. Prevalence, incidence, risk factors, and outcomes. Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. New England Journal Medicine 355:2619–2630.

Pedreira M.L.G., Carvalho W.B.D and Núñez S.C.D. (2009). Oral Care Interventions and Oropharyngeal colonization in children receiving mechanical ventilation. American journal Critical Care 18(4) 319-328

Pitout J., Revathi G., Chow B., Kabera. B., Kariuki S., Nordmann P. and Poirel l. (2008). Metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya. Clinical Microbiology and Infection 14(8): 755–759 Pruitt B. and Jacobs M. (2006). Best practice interventions. How can you prevent ventilator associated pneumonia? Nursing 36(2): 36-42

Rello J., Ulldemolins M., Lisboa ., Koulenti D. , Martn-Loeches I., De Waele J.J Putensen M., Guven M., Deja M., Diaz E. and the EU-VAP/CAP Study Group. (2011). Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia. European respiratory journal 37(6): 1332-1339

Roch A., Wiramus S., Pauly V., Forel J., Guervilly C., Gainnier M. and Papazian L.(2011). Long-term outcome in medical patients aged 80 or over following admission to an intensive care unit.Critical Care 15:R36

Rotstein C., Evans G., Bor ,A ., Grossman R., Light B., Magder S., Taggart B., Weiss K. and George G., Zhanel G.G. (2008). Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Journal of Infectious Diseases Medical Microbiology 19(1):19–53.

Roux D, Gaudry R.D.S., Dreyfuss D., El-Benna J., De Prost N., Denamur E., Saumon G. and Ricard J.D. (2009). Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat. Critical Care Medicine 37:1062–1067

Ruiz M., Torres A, and Ewig S. (2000). Non-invasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. American Journal Respiratory Critical Care Medicine 162:119–125.

Rungruanghiranya S., Somboonwit T.and Kanchanapoom T. (2011). Acinetobacter infection in the intensive care unit. Journal Infectious Diseases Antimicrobial Agents 22:77-92. International Journal Preventive Medicine 2(3):127– 130

Selim A.G., Balalis G., Bhaskar B. and van Driel M.L. (2010). Antibiotics for ventilator associated pneumonia. (Protocol) 9, 2011 of the Cochrane library

Shaw M.I. (2005). Ventilator-associated pneumonia. Current Opinion in Pulmonary

Medicine 11: 236–241.

Sinuff T., Muscedere J., Cook D., Dodek P.and Heyland D. (2008).Ventilator- associated pneumonia. Improving outcomes through guideline implementation. Journal of Critical Care 23: 118-25

Sirvent J.M., Torres A., Vidaur L., Armengol J., De Batlle J. and A.(2000). Tracheal colonization within 24 hours of intubation in patients with head trauma. Risk factor for developing early-onset ventilator-associated pneumonia. Intensive Care Medicine 26(9):1369-1372

Swanson M.J. and Wells D.L. (2013).Empirical antibiotic therapy for ventilator- associated pneumonia. Antibiotics 2013

Torres A., Ferrer M.and Badia J.R.(2010). Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia: Clinical Infectious Diseases. 1(51): S48-53.

Vallés J., Peredo R., Burgueño M., Rodrigues de Freitas A., Millán S., Espasa M., Martín-Loeches I., Ferrer R., Suare D. and Artigas A.(2013). Efficacy of single-dose antibiotic against early-onset pneumonia in comatose patients who are ventilated. Chest 143(5):1219-1225.

Vahdani P., Yaghoubi T. and Aminzadeh Z. (2011). Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia. Annals Saudi Medicine 30(5): 364–36

Vincent J.L., Bihari D.J., Suter P.M., Bruining H.A., White J. and Nicolas- Chanoin M.H. (1995). The prevalence of nosocomial infection in intensive care units in Europe. Results of the European prevalence of infection in intensive care (EPIC) Study. Journal of American Medical association 274(8): 639-44

WHO (2000). World health organization report on infectious diseases 2000. Overcoming antimicrobial resistance WHO/CDS/2000.2 GENEVA 2000